Skip to main content
. 2022 Dec 1;13:1040568. doi: 10.3389/fmicb.2022.1040568

Table 3.

Quality assessment.

Answers
Item Total number of low risk answers/Total number of answers (%) Total number of high risk answers/ Total number of answers (%)
1. Was the study’s sample a close representation of the species of bivalves of a certain geographical area? 1/103 (1%) 102/103 (99%)
2. Was some form of random selection used to select the sample? 10/103 (10%) 93/103 (90%)
3. Was the sample size adequate? 2/103 (2%) 101/103 (98%)
4. Was an acceptable case definition used in the study?
a. Is it possible to trace the AMR results back to the species of bivalves of origin? 69/103 (67%) 34/103 (33%)
b. Is the site of sample collection (retail vs production sites) fully described? 100/103 (97%) 3/103 (3%)
c. Is the period of sample collection identified? 81/103 (79%) 22/103 (21%)
5. Was the study instrument that measured the parameter of interest shown to have reliability and validity (if necessary)?
a. Did the authors refer to CLSI or EUCAST guidelines for antimicrobial susceptibility testing? 85/103 (83%) 18/103 (18%)
b. Did the authors use a control strain for antimicrobial susceptibility testing? 46/103 (45%) 57/103 (55%)
c. Was the source of the breakpoints for interpretation clearly described and was this source a CLSI or an EUCAST document? 61/103 (59%) 42/103 (41%)
6. Was the same mode of data collection used for all subjects? 100/103 (97%) 3/103 (3%)
7. Was the length of the shortest prevalence period for the parameter of interest appropriate? 33/103 (32%) 70/103 (68%)
8. Were the numerator(s) and denominator(s) for the parameter of interest appropriate? 102/103 (99%) 1/103 (1%)